Candriam Equities L Oncology Impact R/ LU1864482788 /
| NAV2024-04-25 | Chg.-0.8600 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 271.4200USD | -0.32% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018 | - | - | - | - | - | - | - | - | - | - | - | -6.01 | - |
| 2019 | 10.23 | 6.17 | 2.65 | -3.66 | -2.58 | 8.68 | 0.29 | -0.29 | -3.18 | 5.10 | 7.95 | 5.04 | +41.40% |
| 2020 | -1.47 | -5.35 | -3.08 | 12.11 | 8.53 | 1.41 | 4.42 | 2.15 | 3.51 | -2.22 | 5.80 | 3.86 | +32.31% |
| 2021 | 0.54 | -4.21 | -0.10 | 2.32 | 0.17 | 3.52 | -0.97 | 5.57 | -3.78 | 3.37 | -6.38 | 3.98 | +3.33% |
| 2022 | -10.50 | -1.76 | 4.64 | -5.86 | -1.34 | 0.03 | 4.36 | -3.15 | -4.72 | 7.04 | 6.06 | -3.45 | -9.77% |
| 2023 | 2.15 | -3.89 | 1.38 | 2.82 | -2.57 | 0.08 | 0.88 | -2.03 | -5.25 | -6.37 | 9.21 | 5.72 | +1.01% |
| 2024 | 1.36 | 4.13 | 1.49 | -4.03 | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 11.20% | 12.19% | 11.98% | 14.75% | 17.31% |
| Sharpe ratio | 0.48 | 2.80 | -0.24 | -0.34 | 0.33 |
| Best month | +5.72% | +9.21% | +9.21% | +9.21% | +12.11% |
| Worst month | -4.03% | -6.37% | -6.37% | -10.50% | -10.50% |
| Maximum loss | -6.78% | -6.78% | -16.46% | -25.23% | -25.23% |
| Outperformance | - | - | - | - | - |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,270.8799 | +1.39% | -2.29% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,426.3899 | +1.52% | -1.92% | |
| Candriam Equities L Oncology Imp... | reinvestment | 197.0900 | -2.02% | -12.32% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,161.1299 | +0.34% | +7.65% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,532.4200 | +1.07% | -3.23% | |
| Candriam Equities L Oncology Imp... | reinvestment | 235.7400 | +2.59% | +6.11% | |
| Candriam Equities L Oncology Imp... | paying dividend | 228.1500 | +0.12% | -5.90% | |
| Candriam Equities L Oncology Imp... | paying dividend | 184.6100 | +0.98% | -3.50% | |
| Candriam Equities L Oncology Imp... | paying dividend | 20,251.0000 | -1.96% | -5.25% | |
| Candriam Equities L Oncology Imp... | reinvestment | 152.9000 | +0.22% | +7.28% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,002.6400 | -1.09% | -9.81% | |
| Candriam Equities L Oncology Imp... | reinvestment | 249.6400 | +3.46% | +8.82% | |
| Candriam Equities L Oncology Imp... | reinvestment | 196.6500 | -2.41% | -13.35% | |
| Candriam Equities L Oncology Imp... | reinvestment | 271.4200 | +0.96% | -3.52% | |
| Candriam Equities L Oncology Imp... | reinvestment | 183.9500 | -1.20% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,782.1899 | +0.66% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,728.4600 | +1.07% | -3.23% | |
| Candriam Equities L Oncology Imp... | reinvestment | 151.6100 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 259.8500 | +0.12% | -5.92% |
Performance
| YTD | +2.80% | ||
|---|---|---|---|
| 6 Months | +17.45% | ||
| 1 Year | +0.96% | ||
| 3 Years | -3.52% | ||
| 5 Years | +58.51% | ||
| Since start | +80.95% | ||
| Year | |||
| 2023 | +1.01% | ||
| 2022 | -9.77% | ||
| 2021 | +3.33% | ||
| 2020 | +32.31% | ||
| 2019 | +41.40% | ||
